Details
Lonza is a global manufacturing and services company that supports the pharmaceutical, biotechnology, and healthcare industries. Headquartered in Switzerland, it specializes in producing ingredients, active pharmaceutical ingredients (APIs), and biologics used in medicines and advanced therapies.
The company provides contract development and manufacturing services (CDMO), helping biotech and pharma companies develop and produce complex drugs, including biologics, cell and gene therapies, and small-molecule medicines. It plays a critical role in bringing innovative treatments from early development through to commercial production.
Lonza operates large-scale production facilities across Europe, the United States, and Asia, serving some of the world’s leading pharmaceutical and biotech companies. Its expertise spans biomanufacturing, microbial and mammalian cell culture, and highly regulated production processes.
The company focuses on enabling healthcare innovation by providing the infrastructure, scientific expertise, and manufacturing capacity needed to produce advanced therapies at scale and ensure reliable global supply of medicines.